Hjelmeland AB - Search Results

1

Acidic stress promotes a glioma stem cell phenotype.

Hjelmeland AB, Wu Q, Heddleston JM, Choudhary GS, MacSwords J, Lathia JD, McLendon R, Lindner D, Sloan A, Rich JN. Hjelmeland AB, et al. Cell Death Differ. 2011 May;18(5):829-40. doi: 10.1038/cdd.2010.150. Epub 2010 Dec 3. Cell Death Differ. 2011. PMID: 21127501 Free PMC article.

2

SB-431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma cell line proliferation and motility.

Hjelmeland MD, Hjelmeland AB, Sathornsumetee S, Reese ED, Herbstreith MH, Laping NJ, Friedman HS, Bigner DD, Wang XF, Rich JN. Hjelmeland MD, et al. Among authors: hjelmeland ab. Mol Cancer Ther. 2004 Jun;3(6):737-45. Mol Cancer Ther. 2004. PMID: 15210860

3

Loss of phosphatase and tensin homologue increases transforming growth factor beta-mediated invasion with enhanced SMAD3 transcriptional activity.

Hjelmeland AB, Hjelmeland MD, Shi Q, Hart JL, Bigner DD, Wang XF, Kontos CD, Rich JN. Hjelmeland AB, et al. Among authors: hjelmeland md. Cancer Res. 2005 Dec 15;65(24):11276-81. doi: 10.1158/0008-5472.CAN-05-3016. Cancer Res. 2005. PMID: 16357132

4

Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor.

Bao S, Wu Q, Sathornsumetee S, Hao Y, Li Z, Hjelmeland AB, Shi Q, McLendon RE, Bigner DD, Rich JN. Bao S, et al. Among authors: hjelmeland ab. Cancer Res. 2006 Aug 15;66(16):7843-8. doi: 10.1158/0008-5472.CAN-06-1010. Cancer Res. 2006. PMID: 16912155

5

AAL881, a novel small molecule inhibitor of RAF and vascular endothelial growth factor receptor activities, blocks the growth of malignant glioma.

Sathornsumetee S, Hjelmeland AB, Keir ST, McLendon RE, Batt D, Ramsey T, Yusuff N, Rasheed BK, Kieran MW, Laforme A, Bigner DD, Friedman HS, Rich JN. Sathornsumetee S, et al. Among authors: hjelmeland ab. Cancer Res. 2006 Sep 1;66(17):8722-30. doi: 10.1158/0008-5472.CAN-06-0284. Cancer Res. 2006. PMID: 16951188

6

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.

Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN. Bao S, et al. Among authors: hjelmeland ab. Nature. 2006 Dec 7;444(7120):756-60. doi: 10.1038/nature05236. Epub 2006 Oct 18. Nature. 2006. PMID: 17051156

7

Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases.

Shi Q, Bao S, Song L, Wu Q, Bigner DD, Hjelmeland AB, Rich JN. Shi Q, et al. Among authors: hjelmeland ab. Oncogene. 2007 Jun 14;26(28):4084-94. doi: 10.1038/sj.onc.1210181. Epub 2007 Jan 8. Oncogene. 2007. PMID: 17213807

8

A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth.

Shi Q, Hjelmeland AB, Keir ST, Song L, Wickman S, Jackson D, Ohmori O, Bigner DD, Friedman HS, Rich JN. Shi Q, et al. Among authors: hjelmeland ab. Mol Carcinog. 2007 Jun;46(6):488-96. doi: 10.1002/mc.20297. Mol Carcinog. 2007. PMID: 17219439

9

Targeting cancer stem cells through L1CAM suppresses glioma growth.

Bao S, Wu Q, Li Z, Sathornsumetee S, Wang H, McLendon RE, Hjelmeland AB, Rich JN. Bao S, et al. Among authors: hjelmeland ab. Cancer Res. 2008 Aug 1;68(15):6043-8. doi: 10.1158/0008-5472.CAN-08-1079. Cancer Res. 2008. PMID: 18676824 Free PMC article.

10

Brain cancer stem cells display preferential sensitivity to Akt inhibition.

Eyler CE, Foo WC, LaFiura KM, McLendon RE, Hjelmeland AB, Rich JN. Eyler CE, et al. Among authors: hjelmeland ab. Stem Cells. 2008 Dec;26(12):3027-36. doi: 10.1634/stemcells.2007-1073. Epub 2008 Sep 18. Stem Cells. 2008. PMID: 18802038 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters